Ahpra registration PHY0002298174
How these guides are written and reviewed →
A lung abscess is a pocket of pus inside the lung. It usually starts when material from the mouth or stomach is breathed into the lung and the bacteria in it take hold, destroying a small area of tissue and leaving a cavity filled with infected fluid. The main symptoms are a cough bringing up large amounts of foul-tasting sputum, fever, night sweats, chest pain and weight loss, and they usually build over weeks rather than days. The treatment is antibiotics, and the course is long — commonly three to six weeks, sometimes longer — because the drug has to penetrate a walled-off cavity. Most people get better on antibiotics alone. This page covers why an abscess forms, how it is diagnosed, what recovery looks like, and what physiotherapy can and cannot safely do.
Definition
A lung abscess is a localised area of infection in which lung tissue has been destroyed and replaced by a cavity containing pus. On imaging it appears as a thick-walled cavity, often with an air–fluid level where pus and air meet. It is distinguished from pneumonia, in which the air sacs fill with inflammatory fluid but the underlying tissue survives, and from empyema, in which the pus sits in the pleural space outside the lung rather than within it. That distinction matters because an empyema usually needs a drain, while an abscess usually does not.
Primary and secondary
| Type | Setting | Usual organisms |
|---|---|---|
| Primary | Aspiration into a previously normal lung; the great majority of cases | Mixed mouth flora — anaerobes, streptococci |
| Secondary | Obstruction by tumour or foreign body, bronchiectasis, infarction, or spread from elsewhere in the body | Depends on the underlying cause; often Staphylococcus aureus, Gram-negatives |
| Acute vs chronic | Under or over six weeks of symptoms at presentation | Chronic presentation is common and delays diagnosis |
Pathophysiology
How a cavity forms
The usual sequence begins with aspiration — material from the mouth, throat or stomach entering the airway. Everyone aspirates small amounts during sleep; what matters is the volume, the bacterial load of the material, and whether cough and mucociliary clearance can remove it. Where those defences are impaired, bacteria establish a pneumonia in the dependent part of the lung. Over one to two weeks the infection outgrows the local blood supply, tissue dies, and the necrotic centre liquefies. If that liquid then erodes into a bronchus it drains, producing the characteristic large volumes of foul sputum, and air enters to create the air–fluid level seen on imaging.
Why the position on the film tells you the mechanism
Aspirated material follows gravity. In a patient who aspirated while lying flat, that means the posterior segments of the upper lobes and the superior segments of the lower lobes — and abscesses appear disproportionately in exactly those places, most often on the right, where the main bronchus is wider and more vertical. An abscess in one of those segments is close to diagnostic of aspiration; an abscess anywhere else raises the question of obstruction or blood-borne spread.1
Co-morbidities
An abscess is nearly always a consequence of something else, and the associated conditions shape both the treatment and the risk of recurrence:
- Impaired consciousness — alcohol dependence, sedative or opioid use, seizures, general anaesthesia, head injury, stroke. The single largest group.
- Swallowing disorders — stroke, Parkinson’s disease, motor neurone disease, oesophageal disease, an unsafe swallow after prolonged intubation.
- Poor dental hygiene and periodontal disease — the reservoir of anaerobic organisms; abscess is uncommon in the edentulous patient without another cause.
- Airway obstruction — lung cancer must be excluded in any older patient, any smoker, and anyone whose cavity does not resolve.
- Chronic suppurative lung disease — bronchiectasis, cystic fibrosis.
- Immunosuppression, diabetes and malnutrition — more aggressive organisms, slower resolution.
- Intravenous drug use — right-sided infective endocarditis with septic emboli produces multiple peripheral cavities rather than a single abscess.
Prevalence
Lung abscess has become uncommon in high-income countries since the arrival of effective antibiotics and better dental care; it is now largely a disease of people with the risk factors above rather than of the general population. It remains substantially more common where those risks cluster — in alcohol dependence, in institutional care, after stroke, and in populations with poor access to dental services. Mortality in an otherwise well patient with a primary aspiration abscess is low, but rises sharply with age, immunosuppression, a large cavity, and where the abscess is secondary to malignancy.2
Causes
- Aspiration — by a wide margin the commonest cause, and the one to assume until another is found.
- Bronchial obstruction — tumour, inhaled foreign body, enlarged lymph nodes.
- Necrotising pneumonia — particularly Staphylococcus aureus, Klebsiella pneumoniae and some pneumococcal strains, which can destroy tissue directly.
- Haematogenous spread — septic emboli from endocarditis, an infected line, or septic thrombophlebitis.
- Direct extension — from an empyema, a subphrenic collection, or the oesophagus.
- Infarction — a pulmonary embolism that infarcts can cavitate and become secondarily infected.
Symptoms
The typical picture
Symptoms usually build slowly, over two to six weeks, which is why an abscess is often mistaken for a slow-to-clear chest infection or for cancer:
- A persistent cough, which at some point begins producing large volumes of sputum — classically foul-smelling and foul-tasting when anaerobes are involved.
- Fever, drenching night sweats and marked fatigue.
- Weight loss and loss of appetite, sometimes several kilograms.
- Pleuritic chest pain if the inflammation reaches the pleural surface.
- Breathlessness, usually milder than the size of the cavity would suggest.
- Coughing up blood — usually small amounts, occasionally large.
Warning signs
Diagnosis
Why the diagnosis matters
Three questions have to be answered, and antibiotics alone answer none of them: is this an abscess or an empyema; is there an obstructing lesion behind it; and is it actually infection at all, rather than a cavitating cancer, tuberculosis or vasculitis? Each has a different treatment, and the imaging appearance alone does not separate them reliably.
How it is diagnosed
A chest radiograph usually shows the cavity, often with an air–fluid level. CT of the chest is the investigation that decides management: it distinguishes abscess from empyema by the shape of the collection and the appearance of its wall, shows an obstructing lesion if one is present, and defines size and position. Sputum culture is taken but is frequently unhelpful, because mouth flora contaminate the sample and anaerobes are difficult to grow; blood cultures are more useful when positive. Bronchoscopy is indicated where obstruction is suspected, where the presentation is atypical, or where the patient does not improve — both to inspect the airway and to obtain uncontaminated samples.
What else it could be
- Cavitating lung cancer — the most important alternative, and the reason a cavity that does not close needs re-investigation rather than more antibiotics.
- Tuberculosis — upper-lobe cavities, weeks of symptoms, weight loss and night sweats overlap almost completely.
- Empyema with a bronchopleural fistula, infected bulla, pulmonary infarct, granulomatosis with polyangiitis, septic emboli, and cavitating fungal infection.
Management
Antibiotics, and the length of the course
Prolonged antibiotic therapy is the treatment, and the duration is the part patients find hardest to accept. Regimens are chosen to cover anaerobes and streptococci — and the course typically runs for several weeks, guided by clinical response and by resolution of the cavity on imaging rather than by a fixed calendar. Treatment usually begins intravenously and switches to oral once fever settles and the patient is improving. Stopping early because the patient feels well is the commonest cause of relapse.
Dealing with the cause
Antibiotics treat this abscess; addressing the cause prevents the next one. That means a formal swallow assessment where aspiration is suspected, dental review and treatment, review of sedating medication and alcohol intake, and bronchoscopy where obstruction is possible.
Drainage and surgery
Most abscesses drain themselves through the airway and need no procedure. Where they do not — a very large cavity, ongoing sepsis despite adequate antibiotics, or an abscess that will not communicate with a bronchus — options are image-guided percutaneous drainage or, uncommonly, surgical resection. Fewer than one in ten patients needs an intervention.3
Supportive care
Nutrition matters more than it is usually given credit for: these patients are frequently several kilograms down and catabolic, and poor nutritional state slows healing. Analgesia adequate to allow deep breathing and effective cough, treatment of anaemia, and control of diabetes all contribute.
Living with a lung abscess
The long middle
The characteristic experience is a long, slow middle: several weeks of tablets, fatigue that lifts gradually, and repeat X-rays that look better far more slowly than the patient feels. The cavity on the film commonly lags weeks to months behind clinical recovery, and a persisting shadow at six weeks is not in itself a treatment failure.
Sputum and appetite
Sputum volume typically increases for a period as the cavity drains, which is a sign of progress rather than deterioration, then tapers. Appetite is usually the last to return; regaining lost weight often takes longer than clearing the infection.
Preventing another one
Where aspiration was the cause, prevention is the part that lasts: following swallowing advice, dental treatment and ongoing dental hygiene, sitting upright to eat and for a period afterwards, and reducing alcohol and sedatives where those contributed.
Prognosis
For an otherwise well person with a primary aspiration abscess, the outlook is good — the great majority recover completely on antibiotics alone, and the lung heals with a small scar. Prognosis is considerably worse where the abscess is secondary to malignancy or occurs in an immunosuppressed, elderly or malnourished patient, and where the cavity is large. Recurrence is uncommon unless the underlying cause — an unsafe swallow, untreated dental sepsis, an obstructing tumour — remains unaddressed.
Role of the physiotherapist
Assessment
Establish the volume, character and pattern of sputum through the day, cough effectiveness, exercise tolerance against the patient’s usual level, and oxygenation on effort as well as at rest. Note the segment involved from the CT — it dictates positioning — and screen for the risk factors that caused the abscess, particularly swallowing and dental problems, referring on where indicated.
Airway clearance — with a genuine caution
Where the abscess is draining into a bronchus, clearance techniques help the patient handle the volume of sputum efficiently and with less exhaustion. The caution is specific and important: vigorous postural drainage of a large, tense abscess carries a theoretical risk of spilling infected material into healthy lung or into the other side, and head-down positioning is generally avoided while the cavity is large and full. In practice, prefer modified upright or side-lying positions, active cycle of breathing with controlled huffs rather than forced coughing bouts, and treat in shorter, more frequent sessions. Discuss the plan with the medical team before applying gravity-assisted drainage to a large cavity.4
Exercise and reconditioning
Deconditioning after weeks of fever, weight loss and inactivity is usually the dominant functional problem by the time the infection is controlled, and it responds well to a graded programme. Start light and progress on symptoms, monitor saturation on effort in the early phase, and expect exercise capacity to recover over weeks. Where lung damage or a long inpatient stay has left a persistent deficit, formal pulmonary rehabilitation is appropriate.
Education
The two messages that change outcomes are finishing the antibiotic course and dealing with the cause. Add breathlessness management and pacing for the recovery period, and huff and cough technique so that clearance is effective without exhausting the patient.
Part 1 · References
- Bartlett JG. The role of anaerobic bacteria in lung abscess. Clin Infect Dis 2005;40(7):923–925.
- Kuhajda I, Zarogoulidis K, Tsirgogianni K, et al. Lung abscess — etiology, diagnostic and treatment options. Ann Transl Med 2015;3(13):183.
- Marra A, Hillejan L, Ukena D. Management of lung abscess. Zentralbl Chir 2015;140 Suppl 1:S47–S53.
- Strickland SL, Rubin BK, Drescher GS, et al. AARC clinical practice guideline: effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients. Respir Care 2013;58(12):2187–2193.
References are numbered in citation order (Vancouver/BMJ style) and were current at the time of writing. Guidelines are living documents — verify against the latest version before clinical use.
More than one of our services applies here, and which combination suits you depends on what your assessment shows.
Clinical evidence
Part 1 covers the same condition without the technical detail. What follows is the evidence base behind it, written for clinicians — the literature, the reasoning and the gaps.
For clinicians: this summary supports clinical reasoning and is not a protocol. Check current guidelines and local policy before applying it, and read it alongside the key references and guidelines directory.
Framing. Lung abscess sits in an unusual evidential position: the management is well established and largely uncontested, yet almost none of it derives from randomised trials. Practice rests on observational series, microbiological reasoning and long clinical experience. The three questions that recur in practice — what to cover, for how long, and when to drain — each have a defensible answer and none has level-one evidence behind it.1
Treatment evidence
- Anaerobic coverage remains the principle, derived from transtracheal-aspirate microbiology from the 1970s establishing mixed anaerobic mouth flora as the dominant pathogens in primary aspiration abscess. Those studies have never been repeated with modern technique, and molecular sequencing suggests the flora is more complex than culture indicated — but the empirical regimens built on that work continue to perform well.1,2
- The retreat from clindamycin is a safety decision, not an efficacy one. Clindamycin outperformed penicillin in two small randomised trials and was standard for years; the shift toward beta-lactam/beta-lactamase-inhibitor combinations reflects Clostridioides difficile risk rather than any demonstrated loss of efficacy.2,3
- Duration is guided by radiology, not by trial data. Courses of several weeks are conventional, extended until the cavity has resolved or stabilised, on the reasoning that antibiotic penetration into a walled-off, poorly perfused cavity is limited. No trial has established a minimum effective duration, and shorter-course strategies validated in pneumonia have not been tested here.3
- Percutaneous drainage is reserved for failure of medical therapy, large cavities, or ongoing sepsis, and is supported by case series reporting high technical success with a low rate of bronchopleural fistula. There is no randomised comparison against continued antibiotics, and selection bias in the series is substantial.4
- Surgical resection is now uncommon — well under one in ten cases — and is largely confined to failed drainage, massive haemoptysis, or an underlying resectable lesion.4
- Airway clearance has no trial evidence in this population. The AARC guideline on non-pharmacological clearance in hospitalised patients does not address abscess specifically; practice is extrapolated from suppurative lung disease generally.5
Clinical reasoning
- Anatomy is diagnostic. Posterior upper-lobe and superior lower-lobe segments, right more than left, in a patient with a risk factor for aspiration, is close to pathognomonic. A cavity outside those segments should prompt a search for obstruction, embolic source or an alternative diagnosis before the aspiration label is accepted.
- The differential is the clinical risk, not the treatment. Cavitating malignancy and tuberculosis both present with weeks of cough, weight loss and night sweats. A cavity that fails to shrink on adequate therapy is a re-investigation trigger — bronchoscopy and repeat imaging — not a reason to escalate antibiotics.
- Distinguish abscess from empyema on CT before planning drainage. The split sign, wall characteristics and the shape of the collection separate them; an empyema needs a chest drain, an abscess usually does not, and drainage of an abscess through the pleural space risks contaminating it.
- Treat the mechanism or expect recurrence. Formal swallow assessment, dental review, and rationalisation of sedatives and alcohol are the interventions that change the recurrence rate; none is an infectious-diseases decision, and all are commonly omitted.
- Physiotherapy caution: head-down gravity-assisted drainage of a large, tense abscess is generally avoided pending evidence of drainage into a bronchus, on the reasoning that spillage into contralateral or dependent healthy lung would be catastrophic. This rests on case reports and physiological plausibility, not on studies. Modified upright and side-lying positions, controlled huffing and shorter more frequent sessions are the pragmatic alternative.5
- Radiological lag is normal. Cavity closure trails clinical recovery by weeks to months. Judge response on fever, sputum volume, inflammatory markers and function — and reserve the film for the question of whether the cavity is closing at all.
Evidence gaps
- No randomised trial has defined optimal antibiotic duration, and no shorter-course strategy has been tested despite success in pneumonia.
- The microbiology underpinning empirical therapy predates molecular methods; modern sequencing of abscess contents has not been translated into regimen design.
- Percutaneous drainage has never been compared with continued medical therapy in a randomised design; the threshold for intervention is therefore institutional.
- Airway clearance in abscess is untested. Both the presumed benefit and the presumed harm of postural drainage are extrapolations, and the caution that shapes practice has no trial behind it.
- Interventions targeting the cause — dental treatment, swallow rehabilitation, medication review — are rarely captured as outcomes in abscess series, so their effect on recurrence is unquantified.
References for the clinical evidence summary
- Bartlett JG. The role of anaerobic bacteria in lung abscess. Clin Infect Dis 2005;40(7):923–925.
- Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983;98(4):466–471.
- Kuhajda I, Zarogoulidis K, Tsirgogianni K, et al. Lung abscess — etiology, diagnostic and treatment options. Ann Transl Med 2015;3(13):183.
- Marra A, Hillejan L, Ukena D. Management of lung abscess. Zentralbl Chir 2015;140 Suppl 1:S47–S53.
- Strickland SL, Rubin BK, Drescher GS, et al. AARC clinical practice guideline: effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients. Respir Care 2013;58(12):2187–2193.
Corrections: If something on this page is wrong, out of date or unclear, we want to know. Email reception@inspireclinic.au with the page name and what you believe is incorrect. Substantive corrections are made promptly, and the guide’s version and last-updated date are changed to reflect it.